NCT00817817View on ClinicalTrials.gov

A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524)

PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

October 1, 2002

Primary Completion Date

May 1, 2003

Study Completion Date

May 1, 2003

Conditions
Asthma
Interventions
DEVICE

MF

One evening dose of dry powder inhaled MF 400 μg (Multidose device).

DEVICE

MF

One evening dose of dry powder inhaled 400 μg (400 μg capsules - Monodose).

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00817817 - A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524) | Biotech Hunter | Biotech Hunter